FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

407101003: Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3501821012 Gefitinib 250 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3679263010 Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
56902501000001113 Gefitinib 250mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

10 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Is a Product containing gefitinib false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has active ingredient Gefitinib false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has active ingredient Substance with protein-tyrosine kinase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has active ingredient Gefitinib false Inferred relationship Existential restriction modifier 1
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has basis of strength substance Gefitinib true Inferred relationship Existential restriction modifier 1
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has presentation strength numerator value 250 false Inferred relationship Existential restriction modifier 1
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has precise active ingredient Gefitinib true Inferred relationship Existential restriction modifier 1
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Is a Product containing gefitinib in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Is a Product containing only gefitinib in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Is a Gefitinib true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspension.gastroenteral ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspension.oral ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Gastroenteral route true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has active ingredient Gefitinib false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has specific active ingredient Gefitinib true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Iressa 250mg tablet Is a False Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Zentiva Pharma UK Ltd) Is a True Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Wockhardt UK Ltd) Is a True Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Genus Pharmaceuticals Ltd) Is a True Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Viatris UK Healthcare Ltd) Is a True Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Accord Healthcare Ltd) Is a True Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Sandoz Ltd) Is a True Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) Is a True Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (A A H Pharmaceuticals Ltd) Is a True Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Iressa 250mg tablets (Originalis B.V.) Is a True Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Iressa 250mg tablets (AstraZeneca UK Ltd) Is a True Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets 30 tablet Has VMP True Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start